美国 · SEC FORM 4
Seer, Inc.
SEER · Nasdaq · CIK 0001726445 · Healthcare · Biotechnology
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
10 同一窗口内观察到的 Form 4 交易行
3 sales · 7 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
Showing the six most active owners; 2 additional owner(s) remain in Form 4 申报证据.
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-08-23 · Farokhzad Omid.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 108,598
- 上期报告
- 87,329
- 日均成交量
- 385,529
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2023-08-23 | Farokhzad Omid | 买入 (P) | Class A Common Stock | 40,000 | USD 2.45 | USD 98,000 | SEC 申报 ↗ |
| 2020-12-09 | Schindel Yair Chaim; aMoon 2 Fund Limited Partnership | 买入 (P) | Class A Common Stock | 789,473 | USD 19.00 | USD 14,999,987 | SEC 申报 ↗ |
| 2020-12-08 | AINSLIE LEE S III | 买入 (P) | Class A Common Stock | 93,380 | USD 19.00 | USD 1,774,220 | SEC 申报 ↗ |
| 2020-12-08 | Schindel Yair Chaim; aMoon 2 Fund Limited Partnership | 买入 (P) | Class A Common Stock | 100,000 | USD 19.00 | USD 1,900,000 | SEC 申报 ↗ |
| 2020-12-08 | Artal Group S.A.; Artal International Management S.A.; Artal International S.C.A.; Artal Treasury Ltd; Invus Public Equities Advisors, LLC; Invus Public Equities, L.P.; Minne Pascal; Stichting Administratiekantoor Westend; Westend S.A. | 买入 (P) | Class A Common Stock | 790,000 | USD 19.00 | USD 15,010,000 | SEC 申报 ↗ |
| 2020-12-08 | MCGUIRE TERRANCE | 买入 (P) | Class A Common Stock | 78,947 | USD 19.00 | USD 1,499,993 | SEC 申报 ↗ |
Form 4 申报证据
19 transaction lines in the latest 365-day window; 179 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Horn David R. | 卖出 (S) | Class A Common Stock | 7,309 | USD 2.03 | USD 14,837 | SEC 申报 ↗ |
| 2026-07-28 | Roelofs Nicolas H PHD | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | Ro Isaac | 奖励／授予 (A) | Class A Common Stock | 12,375 | USD 0.00 | USD 0 | SEC 申报 ↗ |
展开近期 Form 4 证据 (18 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-08-18 | Horn David R. | 卖出 (S) | Class A Common Stock | 7,309 | USD 2.03 | USD 14,837 | SEC 申报 ↗ |
| 2026-07-28 | Roelofs Nicolas H PHD | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | Ro Isaac | 奖励／授予 (A) | Class A Common Stock | 12,375 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | Nishar Dipchand | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | MCGUIRE TERRANCE | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | LANGER ROBERT | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-28 | Gulyani Meeta | 奖励／授予 (A) | Class A Common Stock | 16,500 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-07-08 | Nishar Dipchand | 卖出 (S) | Class A Common Stock | 10,660 | USD 2.18 | USD 23,239 | SEC 申报 ↗ |
| 2026-05-20 | Horn David R. | 卖出 (S) | Class A Common Stock | 7,303 | USD 1.69 | USD 12,342 | SEC 申报 ↗ |
| 2026-05-08 | Bazarko Anthony R. | 奖励／授予 (A) | Class A Common Stock | 75,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-02-18 | Horn David R. | 卖出 (S) | Class A Common Stock | 7,743 | USD 1.99 | USD 15,409 | SEC 申报 ↗ |
| 2026-02-18 | Farokhzad Omid | 卖出 (S) | Class A Common Stock | 24,385 | USD 1.99 | USD 48,526 | SEC 申报 ↗ |
| 2026-02-03 | Horn David R. | 奖励／授予 (A) | Class A Common Stock | 79,000 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2026-02-03 | Farokhzad Omid | 奖励／授予 (A) | Class A Common Stock | 697,162 | USD 0.00 | USD 0 | SEC 申报 ↗ |
| 2025-12-09 | MCGUIRE TERRANCE | C (C) | Class A Common Stock | 4,088 | USD — | USD — | SEC 申报 ↗ |
| 2025-12-09 | Farokhzad Omid | C (C) | Class A Common Stock | 3,555,195 | USD — | USD — | SEC 申报 ↗ |
| 2025-11-19 | Horn David R. | 卖出 (S) | Class A Common Stock | 6,797 | USD 1.97 | USD 13,390 | SEC 申报 ↗ |
| 2025-11-19 | Farokhzad Omid | 卖出 (S) | Class A Common Stock | 33,838 | USD 1.97 | USD 66,661 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | SEER |
| CIK | 0001726445 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 3826 Laboratory Analytical Instruments |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 179 transaction lines from 2020-12-03 to 2026-08-18 11 P purchase lines · 67 S sale lines · 101 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.